12th Edition of International Conference on Neurology and Brain Disorders
October 20-22, 2025
Neuropharmacology and Novel Drug Development
The field of neuropharmacology and novel drug development delves into the biochemical pathways and molecular targets underlying neurological function and dysfunction. This research area is pivotal in driving the creation of innovative drugs, ranging from neuroprotective agents to neuromodulators. Advanced methodologies, such as CRISPR-based genome editing and nanotechnology, are transforming the delivery and effectiveness of neurotherapeutics. Researchers are also focusing on strategies to overcome the challenges of the blood-brain barrier, ensuring enhanced drug delivery to the central nervous system. With a strong focus on addressing unmet clinical needs, neuropharmacology is expanding the frontiers of science, paving the way for groundbreaking solutions to neurological and psychiatric disorders.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Robert B Slocum
University of Kentucky HealthCare, United States
Yong Xiao Wang
Albany Medical College, United States
Roger H Coletti
Interventional Health, PA, United States
Thomas J Webster
Interstellar Therapeutics, United States
Stephen Grossberg
Boston University, United States
George Diaz
Memorial Healthcare Systems, United StatesSubmit your abstract Today
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : The role of beliefs, perception, and behavioural patterns in the evolution of psychophysical disorders
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Missed warning signs – ruptured cerebral aneurysm in a young, healthy woman
John Zakhary, Geauga Medical Center, United States
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : How have we eliminated infection: From the bone to brain ?
Thomas J Webster, Interstellar Therapeutics, United States
Title : Mimicking Deep Brain Stimulation (DBS) via minimally invasive chemo-genetic manipulation of the subthalamic nucleus shows a recovery in parkinsonian behavior in rat models
Nassim Stegamat, Temple University, United States